Grace Therapeutics, Inc. (GRCE)
NASDAQ: GRCE · Real-Time Price · USD
2.940
+0.070 (2.44%)
Aug 4, 2025, 11:35 AM - Market open

HashiCorp Stock Forecast

Stock Price Forecast

The 1 analyst with a 12-month price forecast for HashiCorp stock has a target of 12, which predicts a 308.16% increase from the current stock price of 2.94.

Price Target: $12.00 (+308.16%)
Analyst Consensus: Strong Buy
TargetLowAverageMedianHigh
Price$12$12$12$12
Change+308.16%+308.16%+308.16%+308.16%
* Price targets were last updated on Feb 18, 2025.

Analyst Ratings

According to 1 stock analyst, the rating for HashiCorp is "Strong Buy". This means that the analyst believes this stock is likely to perform very well in the near future and significantly outperform the market.

Recommendation Trends

RatingJun '25Jul '25
Strong Buy11
Buy00
Hold00
Sell00
Strong Sell00
Total11

Latest Forecasts

AnalystFirmRatingRatingActionPrice TargetUpsideDate
HC Wainwright & Co.
HC Wainwright & Co.
Strong Buy
Reiterates
$12
Strong BuyReiterates$12+308.16%Feb 18, 2025
More Analyst Ratings

Financial Forecast

Revenue This Year
n/a
Revenue Next Year
439.58K
EPS This Year
-0.84
from -0.79
EPS Next Year
-1.74
from -0.84
Fiscal YearFY 2021FY 2022FY 2023FY 2024FY 2025FY 2026FY 2026FY 2027
Period EndingMar 31, 2021Mar 31, 2022Mar 31, 2023Mar 31, 2024Mar 31, 2025Mar 31, 2026Mar 31, 2026Mar 31, 2027
Revenue
196.00K-----439.58K10.26M
Revenue Growth
-------2,234.05%
EPS
-7.96-1.60-5.71-1.35-0.79-0.84-1.74-0.58
EPS Growth
--------
Forward PE
--------
No. Analysts
-----644
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue202620272028
High905,02710.5M47.3M
Avg439,5795.8M45.9M
Lown/a1.3M44.1M

Revenue Growth

Revenue Growth202620272028
High-
2,288.6%
715.4%
Avg-
1,218.3%
692.1%
Low-
203.9%
661.0%

EPS Forecast

EPS202620272028
High-1.79-0.680.53
Avg-1.74-0.850.51
Low-1.67-0.990.49

EPS Growth

EPS Growth202620272028
High---
Avg---
Low---
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.